60 records, the earliest from 12 May 2010. As filed with the exchanges; the history is only as deep as the data Tradinity has collected.
60 shown.
Sign in to see more, or upgrade your plan to see the full history. Sign in
| Date | Purpose | Notes |
|---|---|---|
| 28 Jul 2026 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 |
| 29 Apr 2026 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2026 and dividend |
| 27 Jan 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 |
| 17 Oct 2025 | Financial Results | RPG Life Sciences Limited informed that the meeting of the Board of Directors of the Company is scheduled on 17/10/2025 to consider and approve Unaudited Financial Results for the quarter and half year ended September 30, 2025. |
| 25 Jul 2025 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2025 |
| 28 Apr 2025 | Financial Results/Dividend | Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that a meeting of the Board of Directors of the Company is scheduled on Monday, April 28, 2025, inter-alia, to: 1. Consider and approve the Audited Financial Results for the quarter and financial year ended March 31, 2025.2. Recommend dividend, if any, on Equity Shares of the Company for the financial year ended March 31, 2025. Further, pursuant to the Code of Fair Disclosure, Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders of the Company and the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in Securities of the Company by Designated Persons and their immediate relatives, is closed from April 1, 2025 and will continue to remain closed till 48 hours after declaration of results on April 28, 2025. |
| 24 Jan 2025 | Financial Results | To consider and approve the financial results for the period ended December 31, 2024 |
| 7 Nov 2024 | Financial Results | To consider and approve the unaudited financial results for the period ended September 30, 2024 |
| 19 Jul 2024 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2024 |
| 30 Apr 2024 | Financial Results/Dividend | the Audited Financial Results for the quarter and year ended March 31, 2024 and to consider and recommend dividend on equity shares , if any, for the year ended March 31, 2024 |
Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.
